SMi proudly presents its inaugural Drug Discovery conference in London, 2017!
In recent years, the Pharmaceutical/Biotech industry has undergone radical changes which have increased are understanding of drug discovery and development, however there are still many hurdles that the industry face.
The gap between a laboratory discovery and an approved drug on the market is a decade-long process of laboratory testing, evaluation in animal models and human clinical trials that can cost hundreds of millions of dollars. SMi’s inaugural Drug Discovery conference 27th-28th March 2017 aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges.
The conference will bring together industry leaders who will highlight future opportunities for novel therapeutic discovery.
The global market for sequencing products and services reached $3.5 billion in 2012. This market is expected to grow to nearly $4.5 billion in 2013 and nearly 11.7 billion in 2018, a compound annual growth rate (CAGR) of 21.2%.*
Now is the time to invest and join us next March for SMi’s inaugural Drug Discovery conference!
Send this to friend